PDS Biotechnology Corporation
PDSB
$1.26
$0.021.61%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -16.12% | -18.81% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -27.69% | 17.21% | |||
| Operating Income | 27.69% | -17.21% | |||
| Income Before Tax | 25.86% | -16.63% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 25.86% | -28.80% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 25.86% | -28.80% | |||
| EBIT | 27.69% | -17.21% | |||
| EBITDA | 27.73% | -17.24% | |||
| EPS Basic | 27.21% | -28.37% | |||
| Normalized Basic EPS | 27.18% | -16.21% | |||
| EPS Diluted | 27.21% | -28.37% | |||
| Normalized Diluted EPS | 27.18% | -16.21% | |||
| Average Basic Shares Outstanding | 1.85% | 0.31% | |||
| Average Diluted Shares Outstanding | 1.85% | 0.31% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||